News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Shanghai BravoBio Licenses China Rights to Rotavirus Vaccine


6/28/2013 9:03:55 AM

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

by Richard Daverman, PhD

June 27, 2013 -- Shanghai BravoBio Co. has sub-licensed China rights to RotaShield®, an oral rotavirus vaccine that was developed by the International Medica Foundation of the US. The vaccine is the first that can be given to newborns, and it requires only two doses – at two days and two months. Other rotavirus vaccines can’t begin administration until the child is two months old. More details....

Help employers find you! Check out all the jobs and post your resume.

Read at ChinaBio Today


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES